BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K
49 results:

  • 1. Natural products and derivatives in renal, urothelial and testicular cancers: Targeting signaling pathways and therapeutic potential.
    Li D; Wang J; Tuo Z; Yoo KH; Yu Q; Miyamoto A; Zhang C; Ye X; Wei W; Wu R; Feng D
    Phytomedicine; 2024 May; 127():155503. PubMed ID: 38490077
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
    Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
    Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
    [No Abstract]    [Full Text] [Related]  

  • 3. Leptin promotes proliferation of human undifferentiated spermatogonia by activating the pi3k/AKT/mTOR pathway.
    Xin S; Xiaoxuan L; Yixuan Z; Zhikang C
    Am J Reprod Immunol; 2024 Jan; 91(1):e13811. PubMed ID: 38282611
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
    Wolf CL; Pruett C; Lighter D; Jorcyk CL
    Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mitochondrial metabolism-related signature depicts immunophenotype and predicts therapeutic response in testicular germ cell tumors.
    Qiu D; Gao L; Zhang S; Lin G; Yu X
    Medicine (Baltimore); 2023 Sep; 102(37):e35120. PubMed ID: 37713839
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma.
    Mansoor A; Akhter A; Shabani-Rad MT; Deschenes J; Yilmaz A; Trpkov K; Stewart D
    Hematol Oncol; 2023 Dec; 41(5):828-837. PubMed ID: 37291944
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors.
    Gao F; Xu Q; Jiang Y; Lu B
    Sci Rep; 2023 Mar; 13(1):3759. PubMed ID: 36882567
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular analysis of adenocarcinomas of the rete testis demonstrates frequent alterations in genes involved in cell cycle regulation.
    Acosta AM; Al-Obaidy KI; Sholl LM; Ulbright TM; Idrees MT
    Histopathology; 2022 Jul; 81(1):77-83. PubMed ID: 35395117
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. piRNAs and PIWI Proteins as Diagnostic and Prognostic Markers of Genitourinary cancers.
    Hanusek K; Poletajew S; Kryst P; Piekiełko-Witkowska A; Bogusławska J
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204687
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions.
    Takami H
    Curr Oncol Rep; 2022 Jan; 24(1):105-112. PubMed ID: 35059994
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The pi3k/AKT Pathway Is Activated by HGF in NT2D1 Non-Seminoma Cells and Has a Role in the Modulation of Their Malignant Behavior.
    Gesualdi L; Leonetti E; Cucina A; Scicchitano BM; Sorrentino S; Tarsitano MG; Isidori A; Bizzarri M; Filippini A; Riccioli A; Cammarota M; Gigantino V; Ricci G; Catizone A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212946
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genomic characteristics revealed by targeted exon sequencing of testicular germ cell tumors in Japanese men.
    Matsumoto T; Shiota M; Uchiumi T; Ueda S; Tsukahara S; Toshima T; Matsumoto S; Noda N; Eto M; Kang D
    Int J Urol; 2021 Jan; 28(1):40-46. PubMed ID: 33047348
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive cancers.
    Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
    Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities.
    de Vries G; Rosas-Plaza X; van Vugt MATM; Gietema JA; de Jong S
    Cancer Treat Rev; 2020 Aug; 88():102054. PubMed ID: 32593915
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Autophagy Induced by ROS Aggravates Testis Oxidative Damage in Diabetes via Breaking the Feedforward Loop Linking p62 and Nrf2.
    Tian Y; Song W; Xu D; Chen X; Li X; Zhao Y
    Oxid Med Cell Longev; 2020; 2020():7156579. PubMed ID: 32509151
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular insights into hormone regulation via signaling pathways in Sertoli cells: With discussion on infertility and testicular tumor.
    Ni FD; Hao SL; Yang WX
    Gene; 2020 Aug; 753():144812. PubMed ID: 32470507
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The genetic landscapes of urological cancers and their clinical implications in the era of high-throughput genome analysis.
    Light A; Ahmed A; Dasgupta P; Elhage O
    BJU Int; 2020 Jul; 126(1):26-54. PubMed ID: 32306543
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Towards understanding leydigioma: do G protein-coupled estrogen receptor and peroxisome proliferator-activated receptor regulate lipid metabolism and steroidogenesis in Leydig cell tumors?
    Kotula-Balak M; Gorowska-Wojtowicz E; Milon A; Pawlicki P; Tworzydlo W; Płachno BJ; Krakowska I; Hejmej A; Wolski JK; Bilinska B
    Protoplasma; 2020 Jul; 257(4):1149-1163. PubMed ID: 32180008
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Leydig cell tumorigenesis - implication of G-protein coupled membrane estrogen receptor, peroxisome proliferator-activated receptor and xenoestrogen exposure. In vivo and in vitro appraisal.
    Gorowska-Wojtowicz E; Duliban M; Kudrycka M; Dutka P; Pawlicki P; Milon A; Zarzycka M; Placha W; Kotula-Balak M; Ptak A; Wolski JK; Bilinska B
    Tissue Cell; 2019 Dec; 61():51-60. PubMed ID: 31759407
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Dual mTORC1/2 Inhibition Sensitizes testicular cancer Models to Cisplatin Treatment.
    Rosas-Plaza X; de Vries G; Meersma GJ; Suurmeijer AJH; Gietema JA; van Vugt MATM; de Jong S
    Mol Cancer Ther; 2020 Feb; 19(2):590-601. PubMed ID: 31744897
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.